Top Pfizer research exec John Davis joins migration to biotech, lands at Magenta as CMO
Sue Dillon isn’t the only Big Pharma R&D exec to make news this week after making the switch to biotech. Cambridge, MA-based biotech standout Magenta Therapeutics has just recruited Pfizer vet John Davis as their new chief medical officer.
Davis had been the senior vice president and head of early clinical development at Pfizer. He earlier completed a stint at Baxalta after spending 10 years on the faculty at UC San Francisco.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.